MERSANA THERAPEUTICS INC's ticker is MRSN and the CUSIP is 59045L106. A total of 66 filers reported holding MERSANA THERAPEUTICS INC in Q1 2019. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $24,593,154 | +1611.4% | 19,364,688 | +6127.4% | 0.83% | +1560.0% |
Q2 2022 | $1,437,000 | +10.3% | 310,960 | -4.8% | 0.05% | +22.0% |
Q1 2022 | $1,303,000 | -76.9% | 326,578 | -76.5% | 0.04% | -92.8% |
Q2 2019 | $5,639,000 | -53.4% | 1,392,231 | -39.5% | 0.57% | -48.9% |
Q1 2019 | $12,098,000 | +144.1% | 2,300,000 | +364.1% | 1.12% | +150.0% |
Q3 2018 | $4,956,000 | – | 495,618 | – | 0.45% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
RHO CAPITAL PARTNERS INC | 796,458 | $14,830,000 | 12.35% |
Consonance Capital Management LP | 3,468,171 | $64,577,000 | 7.87% |
Sarissa Capital Management LP | 2,837,000 | $52,824,000 | 6.22% |
Bain Capital Life Sciences Investors, LLC | 3,445,667 | $64,158,000 | 5.98% |
Ghost Tree Capital, LLC | 1,050,000 | $19,551,000 | 5.65% |
NEA Management Company, LLC | 5,959,520 | $110,966,000 | 4.70% |
Soleus Capital Management, L.P. | 393,041 | $7,318,000 | 3.88% |
ACUTA CAPITAL PARTNERS, LLC | 667,500 | $12,429,000 | 3.38% |
Avoro Capital Advisors LLC | 6,800,000 | $126,616,000 | 1.80% |
FNY Investment Advisers, LLC | 199,800 | $3,720,000 | 1.57% |